Study of ADVAIR DISKUS and FLOVENT DISKUS taken twice daily in children during fall viral season. - Trial 2015-004887-13
Access comprehensive clinical trial information for 2015-004887-13 through Pure Global AI's free database. This phase not specified trial is sponsored by GlaxoSmithKline Research & Development Ltd and is currently status unknown. The study focuses on Asthma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
GlaxoSmithKline Research & Development Ltd
GlaxoSmithKline
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
The primary efficacy endpoint of this study was the number of exacerbations of asthma (defined above) during the double-blind treatment period. In addition, the time-adjusted relative risk of having an exacerbation was modeled.
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2015-004887-13
Non-Device Trial